Vankomicin

Vankomicin

Klinički podaci
Prodajno ime	Vancocin, Vancocin HCL, Vancoled, Vancor
Drugs.com	Monografija
Način primene	Oralno, intravenozno
Farmakokinetički podaci
Poluvreme eliminacije	6 h
Izlučivanje	Renalno
Identifikatori
CAS broj	1404-90-6 Y
ATC kod	A07AA09 (WHO), J01XA01
PubChem	CID 14969
DrugBank	DB00512 Y
ChemSpider	389935 Y
KEGG	C06689 Y
ChEBI	CHEBI:28001 Y
ChEMBL	CHEMBL262777 Y
Hemijski podaci
Formula	C66H75Cl2N9O24
Molarna masa	1449,254
SMILES CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2
InChI InChI=1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1 Y Key:MYPYJXKWCTUITO-LYRMYLQWSA-N Y

Vankomicin je organsko jedinjenje, koje sadrži 66 atoma ugljenika i ima molekulsku masu od 1449,254 Da.^{[1][2][3][4][5][6][7][8]}

1. ^ Schäfer, Martina; Schneider, Thomas R.; Sheldrick, George M. (1996). „Crystal structure of vancomycin”. Structure. 4 (12): 1509—1515. PMID 8994975. doi:10.1016/S0969-2126(96)00156-6. 
2. ^ Levine, D. P. (2006). „Vancomycin: A history”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42 (Suppl 1): S5—12. PMID 16323120. doi:10.1086/491709. 
3. ^ Small, P. M.; Chambers, H. F. (1990). „Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users”. Antimicrobial Agents and Chemotherapy. 34 (6): 1227—1231. PMC 171789 . PMID 2393284. doi:10.1128/AAC.34.6.1227. 
4. ^ González, C.; Rubio, M.; Romero-Vivas, J.; González, M.; Picazo, J. J. (1999). „Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 29 (5): 1171—1177. PMID 10524959. S2CID 31275966. doi:10.1086/313440. 
5. ^ Sivagnanam, S.; Deleu, D. (2003). „Red man syndrome”. Critical Care (London, England). 7 (2): 119—120. PMC 270616 . PMID 12720556. doi:10.1186/cc1871 . 
6. ^ Cantú, T. G.; Yamanaka-Yuen, N. A.; Lietman, P. S. (1994). „Serum vancomycin concentrations: Reappraisal of their clinical value”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 18 (4): 533—543. PMID 8038306. doi:10.1093/clinids/18.4.533. 
7. ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126. 
8. ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.